Malignant hyperthermia, coexisting disorders, and enzymopathies: risks and management options.

Anesth Analg

Department of Anesthesiology, University of Wisconsin School of Medicine and Public Health, B6/319 Clinical Science Center, 600 Highland Ave., Madison, WI 53792-3272, USA.

Published: October 2009

Clinical episodes and abnormal laboratory tests compatible with a diagnosis of malignant hyperthermia have been observed in patients with a diversity of syndromes, enzymopathies, and coexisting disorders thereby raising the likelihood of causal associations and heightened perioperative risk in others carrying a shared diagnosis. In the present review, we survey available published series, case reports, and the results of contracture testing in patients identified by others to be potentially predisposed to malignant hyperthermia. For most conditions, evidence for a causal relationship with malignant hyperthermia susceptibility is weak. The review concludes with suggestions for clinical management when evidence for or against an association is uncertain.

Download full-text PDF

Source
http://dx.doi.org/10.1213/ane.0b013e3181adca28DOI Listing

Publication Analysis

Top Keywords

malignant hyperthermia
16
coexisting disorders
8
malignant
4
hyperthermia coexisting
4
disorders enzymopathies
4
enzymopathies risks
4
risks management
4
management options
4
options clinical
4
clinical episodes
4

Similar Publications

Objective:  The pyeloureteral anastomosis remains the most challenging part of pyeloplasty. A purpose-built anastomotic device could simplify this step and potentially improve outcomes. The concept of a pyeloureteral magnetic anastomosis device (PUMA) was proven in minipigs, but only in short term.

View Article and Find Full Text PDF

Congenital disorders of glycosylation are rare and present a challenge in management due to interactions with intraoperative medications. We present safe and successful anesthetic management of a pediatric patient with an ALG-13 gene mutation.

View Article and Find Full Text PDF

Volatile Anesthetic Intensive Care Unit Sedation: Comment.

Anesthesiology

February 2025

The North American Malignant Hyperthermia Registry of the Malignant Hyperthermia Association of the United States, Sherburne, New York (M.G.L.).

View Article and Find Full Text PDF

Does the Diagnosis of Intraoperative Malignant Hyperthermia Require Case Termination? A Case Report.

A A Pract

January 2025

From the Department of Anesthesiology, New York Presbyterian Hospital, Weill Cornell Medical Center, New York, NY.

Malignant hyperthermia (MH) is a rare genetic disorder triggered by inhalational anesthetics or depolarizing neuromuscular blocking agents that carries significant mortality if not promptly treated. The following case presents a healthy 39-year-old man who developed MH several hours into an anesthetic exposure. Rapid intraoperative stabilization tactics that paralleled intensive care unit (ICU) level care allowed for continuation of operative management as opposed to case termination given the patient was at high risk for permanent nerve palsy if the case were to be aborted during dissection.

View Article and Find Full Text PDF

Unsafe Care and Fake News in Freeman-Burian Syndrome.

Clin Case Rep

January 2025

Craig R Dufresne Fairfax Virginia USA.

Freeman-Burian syndrome is a rare craniofacial syndrome surrounded by fake news. This situation shows the strong connection between the quality of a literature search and clinical reasoning displayed in patient care, especially in care of patients with rare conditions.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!